Search NLS News

Immunicum has been granted an Orphan Drug Designation (ODD) for ilixadencel in the treatment of Gastrointestinal Stromal Tumors (GIST). This designation confirms the need and potential for ilixadencel as a new treatments for patients with GIST, which is a rare and difficult to treat subgroup of cancers reffered to as Soft Tissue Sarcoma (STS), states […]

When celebrating it’s 10-year anniversary next year, the conference organizers of NLSDays have decided to try out Copenhagen and the newly renovated Bella Centre for the first time. After several years in Stockholm only and a handful of years in either Stockholm or Malmö, where NLSDays will be held September this year, SwedenBIO and the […]

Elicera Therapeutics has been awarded funding from the European Innovation Council (EIC) Accelerator Programme. The grant is sufficient to fully fund Elicera’s planned clinical phase I/II-study evaluating its CAR T-cell therapy ELC-301 in the treatment of B-cell lymphoma, the company states. “This grant has major positive implications for the development of our CAR T-cell therapy, […]

Qlucore employs Erik Söderbäck as head of diagnostics sales. Erik Söderbäck has over 30 years of experience in DNA sequencing and most recently came from QIAGEN Europe, where he was responsible for market development of products and solutions for clinical genomics. He joined the team April 7th. “Through Eriks Söderbäck’s expertise and extensive experience in […]

Life science is booming in the Nordics, and although Denmark and Sweden are by far the leading life science nations of the region, the biotech sector in both Finland and Norway are accelerating and contributing to the idea of the Nordics as a life science powerhouse. All the Nordic countries are among the top-20 over-all […]

Researchers at Karolinska Institutet have identified a new vaccine candidate against pneumococci, bacteria that can cause pneumonia, sepsis, and meningitis. The vaccine molecules comprise nano-sized membrane vesicles produced by the bacteria and provide protection in mice, a new study published in PNAS reports. A pneumococcal vaccine has been included in Sweden’s childhood vaccination programme since […]

The companies and hospitals unite their skills and knowledge for the research of retinitis pigmentosa, a group of genetic eye disorders. The purpose of the collaboration is to examine treatments of retinitis pigmentosa by making use of IQVIA sales data and clinical data collected in the BCB retinal registry. “Retinitis pigmentosa is treated by injecting […]

Asgard Therapeutics has announced that the United States Patent and Trademark Office (USPTO) has granted Asgard’s foundational patent related to the method of reprogramming cells towards the dendritic cell fate. The patent provides protection and market exclusivity of products based in the cell reprogramming method until 2038, such as Asgard’s innovative cancer immunotherapies, describes the […]

Senzime has signed an agreement to acquire 100 percent of the shares in the US company Respiratory Motion, Inc. for an initial consideration of 19 million USD on a cash- and debt-free basis with an additional potential earn-out payment of up to 25 million USD, paid out earliest in 2024. The sellers consist of a […]

The Board of Directors of Spago Nanomedical has resolved to carry out a rights issue with preferential rights for existing shareholders of up to 61.8 MSEK before issue costs. Four (4) shares in Spago Nanomedical entitle for subscription of five (5) new shares in the Rights Issue at a subscription price of SEK 1.20 per […]